Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC)

CUSIP: 359616109

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
-3,003,543
Put/Call ratio
3.3%
SEC-reported price per share
$4.70
Number of holders
117
Value change
-$8,308,464
Number of buys
51
Open additional details 1 more signal available
Number of sells
72
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
66,925,836

Security key

359616109

Report period

Q4 2024

Institutions

117

Top holders

10

Ownership snapshot

Top reported holders of FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Third Rock Ventures III, ...
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5 13F Highest disclosed value: $36,517,883 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $36.52M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
Third Rock Ventures III, L.P. $14.25M
Mark J. Levin $13.37M
RA CAPITAL MANAGEMENT, L.P. $36.52M
BlackRock, Inc. $20.37M
TCG Crossover Management, LLC $18.74M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Third Rock Ventures III, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$14,250,729
4,305,356 shares
— 13 Dec 2022
Mark J. Levin
3/4/5
Director, 10%+ Owner
—
denominator unverified
$13,365,787
4,038,002 shares
— 10 Nov 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$36,517,883
10,229,099 shares
— 30 Sep 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$20,372,301
5,706,527 shares
— 30 Sep 2024
TCG Crossover Management, LLC
13F
Company
13F
—
denominator unverified
$18,742,500
5,250,000 shares
— 30 Sep 2024
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$17,057,146
4,777,912 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
117
Shares
51,666,381
Rows available
117
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
127
Q4 2024 holders
117
Holder diff
-10
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .